Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1067173

Cover Image

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1067173

Mesenchymal Stem Cells Market Share, Size, Trends, Industry Analysis Report, By Products & Services, By Type; By Source Of Isolation, By Indication Outlook, By Application, By Region; Segment Forecast, 2022 - 2030

PUBLISHED:
PAGES: 110 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4250
PDF (Multi User License)
USD 5250
PDF (Enterprise License)
USD 6250

Add to Cart

The global mesenchymal stem cells market size is expected to reach USD 7.25 billion by 2030, according to a new study by Polaris Market Research. The report "Mesenchymal Stem Cells Market Share, Size, Trends, Industry Analysis Report, By Products & Services, By Type; By Source Of Isolation, By Indication Outlook, By Application, By Region; Segment Forecast, 2022 - 2030" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Mesenchymal tissue is adult stem cells, that can be isolated from various sources, mainly from bone marrow, and are capable to differentiate into various types of cells. These cells are mainly involved in the formation and repair of skeletal tissues and for the treatment of diseases like neurological disorders, cardiac ischemia, diabetes. Recent developments in the field of regenerative medicine due to mesenchymal stem cell-based research is expected to fuel the market. The adoption of these products along with the continuous development and improvement in the research field has accelerated the industry's growth.

The prominent factors favoring the industry growth include an increase in the number of clinical trials, approval from regulatory bodies, multiple mesenchymal stem cells isolation sources, wide areas of application, and advancement in technology and medical innovation. The pre-clinical studies have shown that transplantation of MSC has improved cardiovascular repair along with increased apoptosis resistance, promoting the differentiation of myocardial cells, inhibiting fibrosis, reducing the level of inflammation, and promoting angiogenesis. The treatment of genetic and fatal diseases is one of the important drivers boosting market growth.

In July 2020, more than 50 clinical trials were performed using MSC for the development of therapeutics for SARS-CoV-2 infection. Key market players include Thermo Fisher Scientific; PromoCell GmbH; Axol Biosciences, Cytori Therapeutics; Cyagen Biosciences Inc.; Celprogen Inc; BrainStorm Cell; Stemedica Cell Technologies Inc; STEMCELL Technologies Inc;; Smith+Nephew; Lonza AG; ScienCell Research Laboratories; and American Type Culture Collection.

Players in the market are focused on the development of research & development (R&D) laboratories for carrying out their studies. Large companies are collaborating with various small companies and other laboratories to carry out combined research. Various funds and investments have been provided to the MSC research centers.

Polaris Market Research has segmented the mesenchymal stem cells market report based on products & services, type, source of isolation, application, and region:

Mesenchymal Stem Cells Market, Product & Service Outlook (Revenue, USD Billion, 2018 - 2030)

Workflow

Cell sourcing & isolation

Culture & cryopreservation

Differentiation

characterization

Product

Cells & cell lines

Kits, media, & reagents

Others

Services

Mesenchymal Stem Cells Market, Type Outlook (Revenue, USD Billion, 2018 - 2030)

Autologous

Allogeneic

Mesenchymal Stem Cells Market, Source of Isolation Outlook (Revenue, USD Billion, 2018 - 2030)

Bone Marrow

Cord Blood

Peripheral Blood

Fallopian Tube

Fetal liver

Lung

Adipose tissues

Mesenchymal Stem Cells Market, Indication Outlook (Revenue, USD Billion, 2018 - 2030)

Bone and cartilage repair

Cardiovascular disease

Inflammatory & immunological diseases

Liver diseases

Cancer

GvHD

Others

Mesenchymal Stem Cells Market, Application Outlook (Revenue, USD Billion, 2018 - 2030)

Disease modeling

Drug development & discovery

Stem cell banking

Tissue engineering

Toxicology studies

Others

Mesenchymal Stem Cells Market, Regional Outlook (Revenue, USD Billion, 2018 - 2030)

North America

U.S

Canada

Europe

France

Germany

UK

Italy

Spain

Netherlands

Austria

Asia Pacific

China

India

Japan

Malaysia

Australia

Indonesia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Product Code: PM1565

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Mesenchymal Stem Cells Insights

  • 4.1. Meat Substitutes - Industry Snapshot
  • 4.2. Mesenchymal Stem Cells Dynamics
    • 4.2.1. Drivers and Opportunities
    • 4.2.2. Restraints and Challenges
    • 4.2.3. Porter's Five Forces Analysis
      • 4.2.3.1. Bargaining Power of Suppliers (Moderate)
      • 4.2.3.2. Threats of New Entrants: (Low)
      • 4.2.3.3. Bargaining Power of Buyers (Moderate)
      • 4.2.3.4. Threat of Substitute (Moderate)
      • 4.2.3.5. Rivalry among existing firms (High)
    • 4.2.4. PESTLE Analysis
    • 4.2.5. Meat Substitutes Industry Trends
    • 4.2.6. COVID-19 Impact Analysis

5. Global Mesenchymal Stem Cells, by Product & Service

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Mesenchymal Stem Cells, by Product & Service, 2018 - 2030 (USD Billion)
  • 5.3. Workflow
    • 5.3.1. Global Mesenchymal Stem Cells, by Workflow, by Region, 2018 - 2030 (USD Billion)
    • 5.3.2. Cell sourcing & isolation
      • 5.3.2.1. Global Mesenchymal Stem Cells, by Cell sourcing & isolation, 2018 - 2030 (USD Billion)
    • 5.3.3. Culture & cryopreservation
      • 5.3.3.1. Global Mesenchymal Stem Cells, by Culture & Cryopreservation, 2018 - 2030 (USD Billion)
    • 5.3.4. Differentiation
      • 5.3.4.1. Global Mesenchymal Stem Cells, by Differentiation, 2018 - 2030 (USD Billion)
    • 5.3.5. Characterization
      • 5.3.5.1. Global Mesenchymal Stem Cells, by Characterization, 2018 - 2030 (USD Billion)
  • 5.4. Product
    • 5.4.1. Global Mesenchymal Stem Cells, by Product, by Region, 2018 - 2030 (USD Billion)
    • 5.4.2. Cells & cell lines
      • 5.4.2.1. Global Mesenchymal Stem Cells, by Cells & Cell lines, 2018 - 2030 (USD Billion)
    • 5.4.3. Kits, Media, & Reagents
      • 5.4.3.1. Global Mesenchymal Stem Cells, by Kits, Media, & Reagents, 2018 - 2030 (USD Billion)
    • 5.4.4. Others
      • 5.4.4.1. Global Mesenchymal Stem Cells, by Others, 2018 - 2030 (USD Billion)
  • 5.5. Services
    • 5.5.1. Global Mesenchymal Stem Cells, by Services, by Region, 2018 - 2030 (USD Billion)

6. Global Mesenchymal Stem Cells, by Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Mesenchymal Stem Cells, by Type, 2018 - 2030 (USD Billion)
  • 6.3. Autologous
    • 6.3.1. Global Mesenchymal Stem Cells, by Autologous, by Region, 2018 - 2030 (USD Billion)
  • 6.4. Allogenic
    • 6.4.1. Global Mesenchymal Stem Cells, by Allogenic, by Region, 2018 - 2030 (USD Billion)

7. Global Mesenchymal Stem Cells, by Source of Isolation

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Mesenchymal Stem Cells, by Source of Isolation, 2018 - 2030 (USD Billion)
  • 7.3. Bone marrow
    • 7.3.1. Global Mesenchymal Stem Cells, by Bone marrow, by Region, 2018 - 2030 (USD Billion)
  • 7.4. Cord blood
    • 7.4.1. Global Mesenchymal Stem Cells, by Cord blood, by Region, 2018 - 2030 (USD Billion)
  • 7.5. Peripheral Blood
    • 7.5.1. Global Mesenchymal Stem Cells, by Peripheral Blood, by Region, 2018 - 2030 (USD Billion)
  • 7.6. Fallopian tube
    • 7.6.1. Global Mesenchymal Stem Cells, by Fallopian tube, by Region, 2018 - 2030 (USD Billion)
  • 7.7. Fetal liver
    • 7.7.1. Global Other Mesenchymal Stem Cells, by Fetal liver, by Region, 2018 - 2030 (USD Billion)
  • 7.8. Lung
    • 7.8.1. Global Other Mesenchymal Stem Cells, by Lung, by Region, 2018 - 2030 (USD Billion)
  • 7.9. Adipose tissues
    • 7.9.1. Global Other Mesenchymal Stem Cells, by Adipose tissues, by Region, 2018 - 2030 (USD Billion)

8. Global Mesenchymal Stem Cells, by Indication

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Mesenchymal Stem Cells, by Indication, 2018 - 2030 (USD Billion)
  • 8.3. Bone and cartilage repair
    • 8.3.1. Global Mesenchymal Stem Cells, by Bone and cartilage repair, by Region, 2018 - 2030 (USD Billion)
  • 8.4. Cardiovascular disease
    • 8.4.1. Global Mesenchymal Stem Cells, by Cardiovascular disease, by Region, 2018 - 2030 (USD Billion)
  • 8.5. Inflammatory & immunological diseases
    • 8.5.1. Global Mesenchymal Stem Cells, by Inflammatory & immunological diseases, by Region, 2018 - 2030 (USD Billion)
  • 8.6. Liver diseases
    • 8.6.1. Global Mesenchymal Stem Cells, by Liver diseases, by Region, 2018 - 2030 (USD Billion)
  • 8.7. Cancer
    • 8.7.1. Global Mesenchymal Stem Cells, by Cancer, by Region, 2018 - 2030 (USD Billion)
  • 8.8. GvHD
    • 8.8.1. Global Mesenchymal Stem Cells, by GvHD, by Region, 2018 - 2030 (USD Billion)
  • 8.9. Others
    • 8.9.1. Global Mesenchymal Stem Cells, by Others, by Region, 2018 - 2030 (USD Billion)

9. Global Mesenchymal Stem Cells, by Application

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Mesenchymal Stem Cells, by Application, 2018 - 2030 (USD Billion)
  • 9.3. Disease modeling
    • 9.3.1. Global Mesenchymal Stem Cells, by Disease modeling, by Region, 2018 - 2030 (USD Billion)
  • 9.4. Drug development & discovery
    • 9.4.1. Global Mesenchymal Stem Cells, by Drug development & discovery, by Region, 2018 - 2030 (USD Billion)
  • 9.5. Stem cell banking
    • 9.5.1. Global Mesenchymal Stem Cells, by Stem cell banking, by Region, 2018 - 2030 (USD Billion)
  • 9.6. Tissue engineering
    • 9.6.1. Global Other Mesenchymal Stem Cells, by Tissue engineering, by Region, 2018 - 2030 (USD Billion)
  • 9.7. Toxicology studies
    • 9.7.1. Global Other Mesenchymal Stem Cells, by Toxicology studies, by Region, 2018 - 2030 (USD Billion)
  • 9.8. Others
    • 9.8.1. Global Other Mesenchymal Stem Cells, by Others, by Region, 2018 - 2030 (USD Billion)

10. Global Mesenchymal Stem Cells, by Geography

  • 10.1. Key findings
  • 10.2. Introduction
    • 10.2.1. Mesenchymal Stem Cells Assessment, By Geography, 2018 - 2030 (USD Billion)
  • 10.3. Mesenchymal Stem Cells - North America
    • 10.3.1. North America: Mesenchymal Stem Cells, by Product & Service, 2018 - 2030 (USD Billion)
    • 10.3.2. North America: Mesenchymal Stem Cells, by Indication, 2018 - 2030 (USD Billion)
    • 10.3.3. North America: Mesenchymal Stem Cells, by Type, 2018 - 2030 (USD Billion)
    • 10.3.4. North America: Mesenchymal Stem Cells, by Source of Isolation, 2018 - 2030 (USD Billion)
    • 10.3.5. North America: Mesenchymal Stem Cells, by Application, 2018 - 2030 (USD Billion)
    • 10.3.6. Mesenchymal Stem Cells - U.S.
      • 10.3.6.1. U.S.: Mesenchymal Stem Cells, by Product & Service, 2018 - 2030 (USD Billion)
      • 10.3.6.2. U.S.: Mesenchymal Stem Cells, by Indication, 2018 - 2030 (USD Billion)
      • 10.3.6.3. U.S.: Mesenchymal Stem Cells, by Type, 2018 - 2030 (USD Billion)
      • 10.3.6.4. U.S.: Mesenchymal Stem Cells, by Source of Isolation, 2018 - 2030 (USD Billion)
      • 10.3.6.5. U.S.: Mesenchymal Stem Cells, by Application, 2018 - 2030 (USD Billion)
    • 10.3.7. Mesenchymal Stem Cells - Canada
      • 10.3.7.1. Canada: Mesenchymal Stem Cells, by Product & Service, 2018 - 2030 (USD Billion)
      • 10.3.7.2. Canada.: Mesenchymal Stem Cells, by Indication, 2018 - 2030 (USD Billion)
      • 10.3.7.3. Canada: Mesenchymal Stem Cells, by Type, 2018 - 2030 (USD Billion)
      • 10.3.7.4. Canada: Mesenchymal Stem Cells, by Source of Isolation, 2018 - 2030 (USD Billion)
      • 10.3.7.5. Canada: Mesenchymal Stem Cells, by Application, 2018 - 2030 (USD Billion)
  • 10.4. Mesenchymal Stem Cells - Europe
    • 10.4.1. Europe: Mesenchymal Stem Cells, by Product & Service, 2018 - 2030 (USD Billion)
    • 10.4.2. Europe.: Mesenchymal Stem Cells, by Indication, 2018 - 2030 (USD Billion)
    • 10.4.3. Europe: Mesenchymal Stem Cells, by Type, 2018 - 2030 (USD Billion)
    • 10.4.4. Europe: Mesenchymal Stem Cells, by Source of Isolation, 2018 - 2030 (USD Billion)
    • 10.4.5. Europe: Mesenchymal Stem Cells, by Application, 2018 - 2030 (USD Billion)
    • 10.4.6. Mesenchymal Stem Cells - UK
      • 10.4.6.1. UK: Mesenchymal Stem Cells, by Product & Service, 2018 - 2030 (USD Billion)
      • 10.4.6.2. UK.: Mesenchymal Stem Cells, by Indication, 2018 - 2030 (USD Billion)
      • 10.4.6.3. UK: Mesenchymal Stem Cells, by Type, 2018 - 2030 (USD Billion)
      • 10.4.6.4. UK: Mesenchymal Stem Cells, by Source of Isolation, 2018 - 2030 (USD Billion)
      • 10.4.6.5. UK: Mesenchymal Stem Cells, by Application, 2018 - 2030 (USD Billion)
    • 10.4.7. Mesenchymal Stem Cells - France
      • 10.4.7.1. France: Mesenchymal Stem Cells, by Product & Service, 2018 - 2030 (USD Billion)
      • 10.4.7.2. France.: Mesenchymal Stem Cells, by Indication, 2018 - 2030 (USD Billion)
      • 10.4.7.3. France: Mesenchymal Stem Cells, by Type, 2018 - 2030 (USD Billion)
      • 10.4.7.4. France: Mesenchymal Stem Cells, by Source of Isolation, 2018 - 2030 (USD Billion)
      • 10.4.7.5. France: Mesenchymal Stem Cells, by Application, 2018 - 2030 (USD Billion)
    • 10.4.8. Mesenchymal Stem Cells - Germany
      • 10.4.8.1. Germany: Mesenchymal Stem Cells, by Product & Service, 2018 - 2030 (USD Billion)
      • 10.4.8.2. Germany.: Mesenchymal Stem Cells, by Indication, 2018 - 2030 (USD Billion)
      • 10.4.8.3. Germany: Mesenchymal Stem Cells, by Type, 2018 - 2030 (USD Billion)
      • 10.4.8.4. Germany: Mesenchymal Stem Cells, by Source of Isolation, 2018 - 2030 (USD Billion)
      • 10.4.8.5. Germany: Mesenchymal Stem Cells, by Application, 2018 - 2030 (USD Billion)
    • 10.4.9. Mesenchymal Stem Cells - Italy
      • 10.4.9.1. Italy: Mesenchymal Stem Cells, by Product & Service, 2018 - 2030 (USD Billion)
      • 10.4.9.2. Italy.: Mesenchymal Stem Cells, by Indication, 2018 - 2030 (USD Billion)
      • 10.4.9.3. Italy: Mesenchymal Stem Cells, by Type, 2018 - 2030 (USD Billion)
      • 10.4.9.4. Italy: Mesenchymal Stem Cells, by Source of Isolation, 2018 - 2030 (USD Billion)
      • 10.4.9.5. Italy: Mesenchymal Stem Cells, by Application, 2018 - 2030 (USD Billion)
    • 10.4.10. Mesenchymal Stem Cells - Spain
      • 10.4.10.1. Spain: Mesenchymal Stem Cells, by Product & Service, 2018 - 2030 (USD Billion)
      • 10.4.10.2. Spain.: Mesenchymal Stem Cells, by Indication, 2018 - 2030 (USD Billion)
      • 10.4.10.3. Spain: Mesenchymal Stem Cells, by Type, 2018 - 2030 (USD Billion)
      • 10.4.10.4. Spain: Mesenchymal Stem Cells, by Source of Isolation, 2018 - 2030 (USD Billion)
      • 10.4.10.5. Spain: Mesenchymal Stem Cells, by Application, 2018 - 2030 (USD Billion)
    • 10.4.11. Mesenchymal Stem Cells - Netherlands
      • 10.4.11.1. Netherlands: Mesenchymal Stem Cells, by Product & Service, 2018 - 2030 (USD Billion)
      • 10.4.11.2. Netherlands.: Mesenchymal Stem Cells, by Indication, 2018 - 2030 (USD Billion)
      • 10.4.11.3. Netherlands: Mesenchymal Stem Cells, by Type, 2018 - 2030 (USD Billion)
      • 10.4.11.4. Netherlands: Mesenchymal Stem Cells, by Source of Isolation, 2018 - 2030 (USD Billion)
      • 10.4.11.5. Netherlands: Mesenchymal Stem Cells, by Application, 2018 - 2030 (USD Billion)
    • 10.4.12. Mesenchymal Stem Cells - Austria
      • 10.4.12.1. Austria: Mesenchymal Stem Cells, by Product & Service, 2018 - 2030 (USD Billion)
      • 10.4.12.2. Austria.: Mesenchymal Stem Cells, by Indication, 2018 - 2030 (USD Billion)
      • 10.4.12.3. Austria: Mesenchymal Stem Cells, by Type, 2018 - 2030 (USD Billion)
      • 10.4.12.4. Austria: Mesenchymal Stem Cells, by Source of Isolation, 2018 - 2030 (USD Billion)
      • 10.4.12.5. Austria: Mesenchymal Stem Cells, by Application, 2018 - 2030 (USD Billion)
  • 10.5. Mesenchymal Stem Cells - Asia Pacific
    • 10.5.1. Asia Pacific: Mesenchymal Stem Cells, by Product & Service, 2018 - 2030 (USD Billion)
    • 10.5.2. Asia Pacific.: Mesenchymal Stem Cells, by Indication, 2018 - 2030 (USD Billion)
    • 10.5.3. Asia Pacific: Mesenchymal Stem Cells, by Type, 2018 - 2030 (USD Billion)
    • 10.5.4. Asia Pacific: Mesenchymal Stem Cells, by Source of Isolation, 2018 - 2030 (USD Billion)
    • 10.5.5. Asia Pacific: Mesenchymal Stem Cells, by Application, 2018 - 2030 (USD Billion)
    • 10.5.6. Mesenchymal Stem Cells - China
      • 10.5.6.1. China: Mesenchymal Stem Cells, by Product & Service, 2018 - 2030 (USD Billion)
      • 10.5.6.2. China.: Mesenchymal Stem Cells, by Indication, 2018 - 2030 (USD Billion)
      • 10.5.6.3. China: Mesenchymal Stem Cells, by Type, 2018 - 2030 (USD Billion)
      • 10.5.6.4. China: Mesenchymal Stem Cells, by Source of Isolation, 2018 - 2030 (USD Billion)
      • 10.5.6.5. China: Mesenchymal Stem Cells, by Application, 2018 - 2030 (USD Billion)
    • 10.5.7. Mesenchymal Stem Cells - India
      • 10.5.7.1. India: Mesenchymal Stem Cells, by Product & Service, 2018 - 2030 (USD Billion)
      • 10.5.7.2. India.: Mesenchymal Stem Cells, by Indication, 2018 - 2030 (USD Billion)
      • 10.5.7.3. India: Mesenchymal Stem Cells, by Type, 2018 - 2030 (USD Billion)
      • 10.5.7.4. India: Mesenchymal Stem Cells, by Source of Isolation, 2018 - 2030 (USD Billion)
      • 10.5.7.5. India: Mesenchymal Stem Cells, by Application, 2018 - 2030 (USD Billion)
    • 10.5.8. Mesenchymal Stem Cells - Japan
      • 10.5.8.1. Japan: Mesenchymal Stem Cells, by Product & Service, 2018 - 2030 (USD Billion)
      • 10.5.8.2. Japan.: Mesenchymal Stem Cells, by Indication, 2018 - 2030 (USD Billion)
      • 10.5.8.3. Japan: Mesenchymal Stem Cells, by Type, 2018 - 2030 (USD Billion)
      • 10.5.8.4. Japan: Mesenchymal Stem Cells, by Source of Isolation, 2018 - 2030 (USD Billion)
      • 10.5.8.5. Japan: Mesenchymal Stem Cells, by Application, 2018 - 2030 (USD Billion)
    • 10.5.9. Mesenchymal Stem Cells - South Korea
      • 10.5.9.1. South Korea: Mesenchymal Stem Cells, by Product & Service, 2018 - 2030 (USD Billion)
      • 10.5.9.2. South Korea.: Mesenchymal Stem Cells, by Indication, 2018 - 2030 (USD Billion)
      • 10.5.9.3. South Korea: Mesenchymal Stem Cells, by Type, 2018 - 2030 (USD Billion)
      • 10.5.9.4. South Korea: Mesenchymal Stem Cells, by Source of Isolation, 2018 - 2030 (USD Billion)
      • 10.5.9.5. South Korea: Mesenchymal Stem Cells, by Application, 2018 - 2030 (USD Billion)
    • 10.5.10. Mesenchymal Stem Cells - Malaysia
      • 10.5.10.1. Malaysia: Mesenchymal Stem Cells, by Product & Service, 2018 - 2030 (USD Billion)
      • 10.5.10.2. Malaysia.: Mesenchymal Stem Cells, by Indication, 2018 - 2030 (USD Billion)
      • 10.5.10.3. Malaysia: Mesenchymal Stem Cells, by Type, 2018 - 2030 (USD Billion)
      • 10.5.10.4. Malaysia: Mesenchymal Stem Cells, by Source of Isolation, 2018 - 2030 (USD Billion)
      • 10.5.10.5. Malaysia: Mesenchymal Stem Cells, by Application, 2018 - 2030 (USD Billion)
    • 10.5.11. Mesenchymal Stem Cells - Indonesia
      • 10.5.11.1. Indonesia: Mesenchymal Stem Cells, by Product & Service, 2018 - 2030 (USD Billion)
      • 10.5.11.2. Indonesia.: Mesenchymal Stem Cells, by Indication, 2018 - 2030 (USD Billion)
      • 10.5.11.3. Indonesia: Mesenchymal Stem Cells, by Type, 2018 - 2030 (USD Billion)
      • 10.5.11.4. Indonesia: Mesenchymal Stem Cells, by Source of Isolation, 2018 - 2030 (USD Billion)
      • 10.5.11.5. Indonesia: Mesenchymal Stem Cells, by Application, 2018 - 2030 (USD Billion)
  • 10.6. Mesenchymal Stem Cells - Middle East & Africa
    • 10.6.1. Middle East & Africa: Mesenchymal Stem Cells, by Product & Service, 2018 - 2030 (USD Billion)
    • 10.6.2. Middle East & Africa.: Mesenchymal Stem Cells, by Indication, 2018 - 2030 (USD Billion)
    • 10.6.3. Middle East & Africa: Mesenchymal Stem Cells, by Type, 2018 - 2030 (USD Billion)
    • 10.6.4. Middle East & Africa: Mesenchymal Stem Cells, by Source of Isolation, 2018 - 2030 (USD Billion)
    • 10.6.5. Middle East & Africa: Mesenchymal Stem Cells, by Application, 2018 - 2030 (USD Billion)
    • 10.6.6. Mesenchymal Stem Cells - Saudi Arabia
      • 10.6.6.1. Saudi Arabia: Mesenchymal Stem Cells, by Product & Service, 2018 - 2030 (USD Billion)
      • 10.6.6.2. Saudi Arabia.: Mesenchymal Stem Cells, by Indication, 2018 - 2030 (USD Billion)
      • 10.6.6.3. Saudi Arabia: Mesenchymal Stem Cells, by Type, 2018 - 2030 (USD Billion)
      • 10.6.6.4. Saudi Arabia: Mesenchymal Stem Cells, by Source of Isolation, 2018 - 2030 (USD Billion)
      • 10.6.6.5. Saudi Arabia: Mesenchymal Stem Cells, by Application, 2018 - 2030 (USD Billion)
    • 10.6.7. Mesenchymal Stem Cells - UAE
      • 10.6.7.1. UAE: Mesenchymal Stem Cells, by Product & Service, 2018 - 2030 (USD Billion)
      • 10.6.7.2. UAE.: Mesenchymal Stem Cells, by Indication, 2018 - 2030 (USD Billion)
      • 10.6.7.3. UAE: Mesenchymal Stem Cells, by Type, 2018 - 2030 (USD Billion)
      • 10.6.7.4. UAE: Mesenchymal Stem Cells, by Source of Isolation, 2018 - 2030 (USD Billion)
      • 10.6.7.5. UAE: Mesenchymal Stem Cells, by Application, 2018 - 2030 (USD Billion)
    • 10.6.8. Mesenchymal Stem Cells - Israel
      • 10.6.8.1. Israel: Mesenchymal Stem Cells, by Product & Service, 2018 - 2030 (USD Billion)
      • 10.6.8.2. Israel.: Mesenchymal Stem Cells, by Indication, 2018 - 2030 (USD Billion)
      • 10.6.8.3. Israel: Mesenchymal Stem Cells, by Type, 2018 - 2030 (USD Billion)
      • 10.6.8.4. Israel: Mesenchymal Stem Cells, by Source of Isolation, 2018 - 2030 (USD Billion)
      • 10.6.8.5. Israel: Mesenchymal Stem Cells, by Application, 2018 - 2030 (USD Billion)
    • 10.6.9. Mesenchymal Stem Cells - South Africa
      • 10.6.9.1. South Africa: Mesenchymal Stem Cells, by Product & Service, 2018 - 2030 (USD Billion)
      • 10.6.9.2. South Africa.: Mesenchymal Stem Cells, by Indication, 2018 - 2030 (USD Billion)
      • 10.6.9.3. South Africa: Mesenchymal Stem Cells, by Type, 2018 - 2030 (USD Billion)
      • 10.6.9.4. South Africa: Mesenchymal Stem Cells, by Source of Isolation, 2018 - 2030 (USD Billion)
      • 10.6.9.5. South Africa: Mesenchymal Stem Cells, by Application, 2018 - 2030 (USD Billion)
  • 10.7. Mesenchymal Stem Cells - Latin America
    • 10.7.1. Latin America: Mesenchymal Stem Cells, by Product & Service, 2018 - 2030 (USD Billion)
    • 10.7.2. Latin America.: Mesenchymal Stem Cells, by Indication, 2018 - 2030 (USD Billion)
    • 10.7.3. Latin America: Mesenchymal Stem Cells, by Type, 2018 - 2030 (USD Billion)
    • 10.7.4. Latin America: Mesenchymal Stem Cells, by Source of Isolation, 2018 - 2030 (USD Billion)
    • 10.7.5. Latin America: Mesenchymal Stem Cells, by Application, 2018 - 2030 (USD Billion)
    • 10.7.6. Mesenchymal Stem Cells - Mexico
      • 10.7.6.1. Mexico: Mesenchymal Stem Cells, by Product & Service, 2018 - 2030 (USD Billion)
      • 10.7.6.2. Mexico.: Mesenchymal Stem Cells, by Indication, 2018 - 2030 (USD Billion)
      • 10.7.6.3. Mexico: Mesenchymal Stem Cells, by Type, 2018 - 2030 (USD Billion)
      • 10.7.6.4. Mexico: Mesenchymal Stem Cells, by Source of Isolation, 2018 - 2030 (USD Billion)
      • 10.7.6.5. Mexico: Mesenchymal Stem Cells, by Application, 2018 - 2030 (USD Billion)
    • 10.7.7. Mesenchymal Stem Cells - Brazil
      • 10.7.7.1. Brazil: Mesenchymal Stem Cells, by Product & Service, 2018 - 2030 (USD Billion)
      • 10.7.7.2. Brazil.: Mesenchymal Stem Cells, by Indication, 2018 - 2030 (USD Billion)
      • 10.7.7.3. Brazil: Mesenchymal Stem Cells, by Type, 2018 - 2030 (USD Billion)
      • 10.7.7.4. Brazil: Mesenchymal Stem Cells, by Source of Isolation, 2018 - 2030 (USD Billion)
      • 10.7.7.5. Brazil: Mesenchymal Stem Cells, by Application, 2018 - 2030 (USD Billion)
    • 10.7.8. Mesenchymal Stem Cells - Argentina
      • 10.7.8.1. Argentina: Mesenchymal Stem Cells, by Product & Service, 2018 - 2030 (USD Billion)
      • 10.7.8.2. Argentina.: Mesenchymal Stem Cells, by Indication, 2018 - 2030 (USD Billion)
      • 10.7.8.3. Argentina: Mesenchymal Stem Cells, by Type, 2018 - 2030 (USD Billion)
      • 10.7.8.4. Argentina: Mesenchymal Stem Cells, by Source of Isolation, 2018 - 2030 (USD Billion)
      • 10.7.8.5. Argentina: Mesenchymal Stem Cells, by Application, 2018 - 2030 (USD Billion)

11. Competitive Landscape

  • 11.1. Expansion and Acquisition Analysis
    • 11.1.1. Expansion
    • 11.1.2. Acquisitions
  • 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

  • 12.1. American Type Culture Collection
    • 12.1.1. Company Overview
    • 12.1.2. Financial PerIndicationance
    • 12.1.3. Product Benchmarking
    • 12.1.4. Recent Development
  • 12.2. Axol Biosciences
    • 12.2.1. Company Overview
    • 12.2.2. Financial PerIndicationance
    • 12.2.3. Product Benchmarking
    • 12.2.4. Recent Development
  • 12.3. BrainStorm Cell
    • 12.3.1. Company Overview
    • 12.3.2. Financial PerIndicationance
    • 12.3.3. Product Benchmarking
    • 12.3.4. Recent Development
  • 12.4. Celprogen Inc
    • 12.4.1. Company Overview
    • 12.4.2. Financial PerIndicationance
    • 12.4.3. Product Benchmarking
    • 12.4.4. Recent Development
  • 12.5. Cyagen Biosciences Inc
    • 12.5.1. Company Overview
    • 12.5.2. Financial PerIndicationance
    • 12.5.3. Product Benchmarking
    • 12.5.4. Recent Development
  • 12.6. Cytori Therapeutics
    • 12.6.1. Company Overview
    • 12.6.2. Financial PerIndicationance
    • 12.6.3. Product & Service Benchmarking
    • 12.6.4. Recent Development
  • 12.7. Lonza AG
    • 12.7.1. Company Overview
    • 12.7.2. Financial PerIndicationance
    • 12.7.3. Product & Service Benchmarking
    • 12.7.4. Recent Development
  • 12.8. PromoCell GmbH
    • 12.8.1. Company Overview
    • 12.8.2. Financial PerIndicationance
    • 12.8.3. Product Benchmarking
    • 12.8.4. Recent Development
  • 12.9. ScienCell Research Laboratories
    • 12.9.1. Company Overview
    • 12.9.2. Financial PerIndicationance
    • 12.9.3. Product Benchmarking
    • 12.9.4. Recent Development
  • 12.10. Smith+Nephew
    • 12.10.1. Company Overview
    • 12.10.2. Financial PerIndicationance
    • 12.10.3. Product Benchmarking
    • 12.10.4. Recent Development
  • 12.11. STEMCELL Technologies Inc
    • 12.11.1. Company Overview
    • 12.11.2. Financial PerIndicationance
    • 12.11.3. Product Benchmarking
    • 12.11.4. Recent Development
  • 12.12. Stemedica Cell Technologies Inc
    • 12.12.1. Company Overview
    • 12.12.2. Financial PerIndicationance
    • 12.12.3. Product Benchmarking
    • 12.12.4. Recent Development
  • 12.13. Thermo Fisher Scientific
    • 12.13.1. Company Overview
    • 12.13.2. Financial PerIndicationance
    • 12.13.3. Product Benchmarking
    • 12.13.4. Recent Development
Product Code: PM1565

List of Tables

  • Table 1 Global Mesenchymal Stem Cells, By Product & Service, 2018 - 2030 (USD Billion)
  • Table 2 Global Mesenchymal Stem Cells, by Type, by Region, 2018 - 2030 (USD Billion)
  • Table 3 Global Mesenchymal Stem Cells, by Source of Isolation, by Region, 2018 - 2030 (USD Billion)
  • Table 4 Global Mesenchymal Stem Cells, by Indication, by Region, 2018 - 2030 (USD Billion)
  • Table 5 Global Mesenchymal Stem Cells, by Application, by Region, 2018 - 2030 (USD Billion)
  • Table 6 Mesenchymal Stem Cells Assessment, By Geography, 2018 - 2030 (USD Billion)
  • Table 7 North America: Mesenchymal Stem Cells, By Product & Service, 2018 - 2030 (USD Billion)
  • Table 8 North America: Mesenchymal Stem Cells, By Type, 2018 - 2030 (USD Billion)
  • Table 9 North America: Mesenchymal Stem Cells, By Source of Isolation, 2018 - 2030 (USD Billion)
  • Table 10 North America: Mesenchymal Stem Cells, By Indication, 2018 - 2030 (USD Billion)
  • Table 11 North America: Mesenchymal Stem Cells, By Application, 2018 - 2030 (USD Billion)
  • Table 12 U.S.: Mesenchymal Stem Cells, By Product & Service, 2018 - 2030 (USD Billion)
  • Table 13 U.S.: Mesenchymal Stem Cells, By Type, 2018 - 2030 (USD Billion)
  • Table 14 U.S.: Mesenchymal Stem Cells, By Source of Isolation, 2018 - 2030 (USD Billion)
  • Table 15 U.S.: Mesenchymal Stem Cells, By Indication, 2018 - 2030 (USD Billion)
  • Table 16 U.S.: Mesenchymal Stem Cells, By Application, 2018 - 2030 (USD Billion)
  • Table 17 Canada: Mesenchymal Stem Cells, By Product & Service, 2018 - 2030 (USD Billion)
  • Table 18 Canada: Mesenchymal Stem Cells, By Type, 2018 - 2030 (USD Billion)
  • Table 19 Canada: Mesenchymal Stem Cells, By Source of Isolation, 2018 - 2030 (USD Billion)
  • Table 20 Canada: Mesenchymal Stem Cells, By Indication, 2018 - 2030 (USD Billion)
  • Table 21 Canada: Mesenchymal Stem Cells, By Application, 2018 - 2030 (USD Billion)
  • Table 22 Europe: Mesenchymal Stem Cells, By Product & Service, 2018 - 2030 (USD Billion)
  • Table 23 Europe: Mesenchymal Stem Cells, By Type, 2018 - 2030 (USD Billion)
  • Table 24 Europe: Mesenchymal Stem Cells, By Source of Isolation, 2018 - 2030 (USD Billion)
  • Table 25 Europe: Mesenchymal Stem Cells, By Indication, 2018 - 2030 (USD Billion)
  • Table 26 Europe: Mesenchymal Stem Cells, By Application, 2018 - 2030 (USD Billion)
  • Table 27 UK: Mesenchymal Stem Cells, By Product & Service, 2018 - 2030 (USD Billion)
  • Table 28 UK: Mesenchymal Stem Cells, By Type, 2018 - 2030 (USD Billion)
  • Table 29 UK: Mesenchymal Stem Cells, By Source of Isolation, 2018 - 2030 (USD Billion)
  • Table 30 UK: Mesenchymal Stem Cells, By Indication, 2018 - 2030 (USD Billion)
  • Table 31 UK: Mesenchymal Stem Cells, By Applications, 2018 - 2030 (USD Billion)
  • Table 32 France: Mesenchymal Stem Cells, By Product & Service, 2018 - 2030 (USD Billion)
  • Table 33 France: Mesenchymal Stem Cells, By Type, 2018 - 2030 (USD Billion)
  • Table 34 France: Mesenchymal Stem Cells, By Source of Isolation, 2018 - 2030 (USD Billion)
  • Table 35 France: Mesenchymal Stem Cells, By Indication, 2018 - 2030 (USD Billion)
  • Table 36 France: Mesenchymal Stem Cells, By Application, 2018 - 2030 (USD Billion)
  • Table 37 Germany: Mesenchymal Stem Cells, By Product & Service, 2018 - 2030 (USD Billion)
  • Table 38 Germany: Mesenchymal Stem Cells, By Type, 2018 - 2030 (USD Billion)
  • Table 39 Germany: Mesenchymal Stem Cells, By Source of Isolation, 2018 - 2030 (USD Billion)
  • Table 40 Germany: Mesenchymal Stem Cells, By Indication, 2018 - 2030 (USD Billion)
  • Table 41 Germany: Mesenchymal Stem Cells, By Application, 2018 - 2030 (USD Billion)
  • Table 42 Italy: Mesenchymal Stem Cells, By Product & Service, 2018 - 2030 (USD Billion)
  • Table 43 Italy: Mesenchymal Stem Cells, By Type, 2018 - 2030 (USD Billion)
  • Table 44 Italy: Mesenchymal Stem Cells, By Source of Isolation, 2018 - 2030 (USD Billion)
  • Table 45 Italy: Mesenchymal Stem Cells, By Indication, 2018 - 2030 (USD Billion)
  • Table 46 Italy: Mesenchymal Stem Cells, By Application, 2018 - 2030 (USD Billion)
  • Table 47 Spain: Mesenchymal Stem Cells, By Product & Service, 2018 - 2030 (USD Billion)
  • Table 48 Spain: Mesenchymal Stem Cells, By Type, 2018 - 2030 (USD Billion)
  • Table 49 Spain: Mesenchymal Stem Cells, By Source of Isolation, 2018 - 2030 (USD Billion)
  • Table 50 Spain: Mesenchymal Stem Cells, By Indication, 2018 - 2030 (USD Billion)
  • Table 51 Spain: Mesenchymal Stem Cells, By Application, 2018 - 2030 (USD Billion)
  • Table 52 Netherlands: Mesenchymal Stem Cells, By Product & Service, 2018 - 2030 (USD Billion)
  • Table 53 Netherlands: Mesenchymal Stem Cells, By Type, 2018 - 2030 (USD Billion)
  • Table 54 Netherlands: Mesenchymal Stem Cells, By Source of Isolation, 2018 - 2030 (USD Billion)
  • Table 55 Netherlands: Mesenchymal Stem Cells, By Indication, 2018 - 2030 (USD Billion)
  • Table 56 Netherlands: Mesenchymal Stem Cells, By Application, 2018 - 2030 (USD Billion)
  • Table 57 Austria: Mesenchymal Stem Cells, By Product & Service, 2018 - 2030 (USD Billion)
  • Table 58 Austria: Mesenchymal Stem Cells, By Type, 2018 - 2030 (USD Billion)
  • Table 59 Austria: Mesenchymal Stem Cells, By Source of Isolation, 2018 - 2030 (USD Billion)
  • Table 60 Austria: Mesenchymal Stem Cells, By Indication, 2018 - 2030 (USD Billion)
  • Table 61 Austria: Mesenchymal Stem Cells, By Application, 2018 - 2030 (USD Billion)
  • Table 62 Asia Pacific: Mesenchymal Stem Cells, By Product & Service, 2018 - 2030 (USD Billion)
  • Table 63 Asia Pacific: Mesenchymal Stem Cells, By Type, 2018 - 2030 (USD Billion)
  • Table 64 Asia Pacific: Mesenchymal Stem Cells, By Source of Isolation, 2018 - 2030 (USD Billion)
  • Table 65 Asia Pacific: Mesenchymal Stem Cells, By Indication, 2018 - 2030 (USD Billion)
  • Table 66 Asia Pacific: Mesenchymal Stem Cells, By Application, 2018 - 2030 (USD Billion)
  • Table 67 China: Mesenchymal Stem Cells, By Product & Service, 2018 - 2030 (USD Billion)
  • Table 68 China: Mesenchymal Stem Cells, By Type, 2018 - 2030 (USD Billion)
  • Table 69 China: Mesenchymal Stem Cells, By Source of Isolation, 2018 - 2030 (USD Billion)
  • Table 70 China: Mesenchymal Stem Cells, By Indication, 2018 - 2030 (USD Billion)
  • Table 71 China: Mesenchymal Stem Cells, By Application, 2018 - 2030 (USD Billion)
  • Table 72 India: Mesenchymal Stem Cells, By Product & Service, 2018 - 2030 (USD Billion)
  • Table 73 India: Mesenchymal Stem Cells, By Type, 2018 - 2030 (USD Billion)
  • Table 74 India: Mesenchymal Stem Cells, By Source of Isolation, 2018 - 2030 (USD Billion)
  • Table 75 India: Mesenchymal Stem Cells, By Indication, 2018 - 2030 (USD Billion)
  • Table 76 India: Mesenchymal Stem Cells, By Application, 2018 - 2030 (USD Billion)
  • Table 77 Japan: Mesenchymal Stem Cells, By Product & Service, 2018 - 2030 (USD Billion)
  • Table 78 Japan: Mesenchymal Stem Cells, By Indication, 2018 - 2030 (USD Billion)
  • Table 79 Japan: Mesenchymal Stem Cells, By Source of Isolation, 2018 - 2030 (USD Billion)
  • Table 80 Japan: Mesenchymal Stem Cells, By Type, 2018 - 2030 (USD Billion)
  • Table 81 Japan: Mesenchymal Stem Cells, By Application, 2018 - 2030 (USD Billion)
  • Table 82 Malaysia: Mesenchymal Stem Cells, By Product & Service, 2018 - 2030 (USD Billion)
  • Table 83 Malaysia: Mesenchymal Stem Cells, By Type, 2018 - 2030 (USD Billion)
  • Table 84 Malaysia: Mesenchymal Stem Cells, By Source of Isolation, 2018 - 2030 (USD Billion)
  • Table 85 Malaysia: Mesenchymal Stem Cells, By Indication, 2018 - 2030 (USD Billion)
  • Table 86 Malaysia: Mesenchymal Stem Cells, By Application, 2018 - 2030 (USD Billion)
  • Table 87 Indonesia: Mesenchymal Stem Cells, By Product & Service, 2018 - 2030 (USD Billion)
  • Table 88 Indonesia: Mesenchymal Stem Cells, By Type, 2018 - 2030 (USD Billion)
  • Table 89 Indonesia: Mesenchymal Stem Cells, By Source of Isolation, 2018 - 2030 (USD Billion)
  • Table 90 Indonesia: Mesenchymal Stem Cells, By Indication, 2018 - 2030 (USD Billion)
  • Table 91 Indonesia: Mesenchymal Stem Cells, By Application, 2018 - 2030 (USD Billion)
  • Table 92 South Korea: Mesenchymal Stem Cells, By Product & Service, 2018 - 2030 (USD Billion)
  • Table 93 South Korea: Mesenchymal Stem Cells, By Type, 2018 - 2030 (USD Billion)
  • Table 94 South Korea: Mesenchymal Stem Cells, By Source of Isolation, 2018 - 2030 (USD Billion)
  • Table 95 South Korea: Mesenchymal Stem Cells, By Indication, 2018 - 2030 (USD Billion)
  • Table 96 South Korea: Mesenchymal Stem Cells, By Applications, 2018 - 2030 (USD Billion)
  • Table 97 Middle East & Africa: Mesenchymal Stem Cells, By Product & Service, 2018 - 2030 (USD Billion)
  • Table 98 Middle East & Africa: Mesenchymal Stem Cells, By Type, 2018 - 2030 (USD Billion)
  • Table 99 Middle East & Africa: Mesenchymal Stem Cells, By Source of Isolation, 2018 - 2030 (USD Billion)
  • Table 100 Middle East & Africa: Mesenchymal Stem Cells, By Indication, 2018 - 2030 (USD Billion)
  • Table 101 Middle East & Africa: Mesenchymal Stem Cells, By Application, 2018 - 2030 (USD Billion)
  • Table 102 Saudi Arabia: Mesenchymal Stem Cells, By Product & Service, 2018 - 2030 (USD Billion)
  • Table 103 Saudi Arabia: Mesenchymal Stem Cells, By Type, 2018 - 2030 (USD Billion)
  • Table 104 Saudi Arabia: Mesenchymal Stem Cells, By Source of Isolation, 2018 - 2030 (USD Billion)
  • Table 105 Saudi Arabia: Mesenchymal Stem Cells, By Indication, 2018 - 2030 (USD Billion)
  • Table 106 Saudi Arabia: Mesenchymal Stem Cells, By Application, 2018 - 2030 (USD Billion)
  • Table 107 Israel: Mesenchymal Stem Cells, By Product & Service, 2018 - 2030 (USD Billion)
  • Table 108 Israel: Mesenchymal Stem Cells, By Type, 2018 - 2030 (USD Billion)
  • Table 109 Israel: Mesenchymal Stem Cells, By Source of Isolation, 2018 - 2030 (USD Billion)
  • Table 110 Israel: Mesenchymal Stem Cells, By Indication, 2018 - 2030 (USD Billion)
  • Table 111 Israel: Mesenchymal Stem Cells, By Application, 2018 - 2030 (USD Billion)
  • Table 112 South Africa: Mesenchymal Stem Cells, By Product & Service, 2018 - 2030 (USD Billion)
  • Table 113 South Africa: Mesenchymal Stem Cells, By Type, 2018 - 2030 (USD Billion)
  • Table 114 South Africa: Mesenchymal Stem Cells, By Source of Isolation, 2018 - 2030 (USD Billion)
  • Table 115 South Africa: Mesenchymal Stem Cells, By Indication, 2018 - 2030 (USD Billion)
  • Table 116 South Africa: Mesenchymal Stem Cells, By Application, 2018 - 2030 (USD Billion)
  • Table 117 UAE: Mesenchymal Stem Cells, By Product & Service, 2018 - 2030 (USD Billion)
  • Table 118 UAE: Mesenchymal Stem Cells, By Type, 2018 - 2030 (USD Billion)
  • Table 119 UAE: Mesenchymal Stem Cells, By Source of Isolation, 2018 - 2030 (USD Billion)
  • Table 120 UAE: Mesenchymal Stem Cells, By Indication, 2018 - 2030 (USD Billion)
  • Table 121 UAE: Mesenchymal Stem Cells, By Application, 2018 - 2030 (USD Billion)
  • Table 122 Latin America: Mesenchymal Stem Cells, By Product & Service, 2018 - 2030 (USD Billion)
  • Table 123 Latin America: Mesenchymal Stem Cells, By Type, 2018 - 2030 (USD Billion)
  • Table 124 Latin America: Mesenchymal Stem Cells, By Source of Isolation, 2018 - 2030 (USD Billion)
  • Table 125 Latin America: Mesenchymal Stem Cells, By Indication, 2018 - 2030 (USD Billion)
  • Table 126 Latin America: Mesenchymal Stem Cells, By Application, 2018 - 2030 (USD Billion)
  • Table 127 Brazil: Mesenchymal Stem Cells, By Product & Service, 2018 - 2030 (USD Billion)
  • Table 128 Brazil: Mesenchymal Stem Cells, By Type, 2018 - 2030 (USD Billion)
  • Table 129 Brazil: Mesenchymal Stem Cells, By Source of Isolation, 2018 - 2030 (USD Billion)
  • Table 130 Brazil: Mesenchymal Stem Cells, By Indication, 2018 - 2030 (USD Billion)
  • Table 131 Brazil: Mesenchymal Stem Cells, By Application, 2018 - 2030 (USD Billion)
  • Table 132 Mexico: Mesenchymal Stem Cells, By Product & Service, 2018 - 2030 (USD Billion)
  • Table 133 Mexico: Mesenchymal Stem Cells, By Type, 2018 - 2030 (USD Billion)
  • Table 134 Mexico: Mesenchymal Stem Cells, By Source of Isolation, 2018 - 2030 (USD Billion)
  • Table 135 Mexico: Mesenchymal Stem Cells, By Indication, 2018 - 2030 (USD Billion)
  • Table 136 Mexico: Mesenchymal Stem Cells, By Application, 2018 - 2030 (USD Billion)
  • Table 137 Argentina: Mesenchymal Stem Cells, By Product & Service, 2018 - 2030 (USD Billion)
  • Table 138 Argentina: Mesenchymal Stem Cells, By Type, 2018 - 2030 (USD Billion)
  • Table 139 Argentina: Mesenchymal Stem Cells, By Source of Isolation, 2018 - 2030 (USD Billion)
  • Table 140 Argentina: Mesenchymal Stem Cells, By Indication, 2018 - 2030 (USD Billion)
  • Table 141 Argentina: Mesenchymal Stem Cells, By Application, 2018 - 2030 (USD Billion)

List of Figures

Figure 1. Global Mesenchymal Stem Cells, 2018 - 2030 (USD Billion)

Figure 2. Integrated Ecosystem

Figure 3. Research Methodology: Top-Down & Bottom-Up Approach

Figure 4. Market by Geography

Figure 5. Porter's Five Forces

Figure 6. Market by Product & Service

Figure 7. Global Mesenchymal Stem Cells, by Product & Service, 2021 & 2030 (USD Billion)

Figure 8. Market by Indication

Figure 9. Global Mesenchymal Stem Cells, by Indication, 2021 & 2030 (USD Billion)

Figure 10. Market by Type

Figure 11. Global Mesenchymal Stem Cells, by Type, 2021 & 2030 (USD Billion)

Figure 12. Market by Source of Isolation

Figure 13. Global Mesenchymal Stem Cells, by Source of Isolation, 2021 & 2030 (USD Billion)

Figure 14. Market by Application

Figure 15. Global Mesenchymal Stem Cells, by Application, 2021 & 2030 (USD Billion)

Figure 16. Mesenchymal Stem Cells Assessment, By Geography, 2018 - 2030 (USD Billion)

Figure 17. Strategic Analysis - Mesenchymal Stem Cells

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!